Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Naturally-occurring mutation in the calcium-sensing receptor reveals the significance of extracellular domain loop III region for class C G-protein-coupled receptor function.
[familial hypocalciuric hypercalcemia]
Inactivating
mutations
of
the
calcium-sensing
receptor
(
CaSR
)
cause
familial
hypocalciuric
hypercalcemia
and
neonatal
severe
hyperparathyroidism
.
Most
mutations
are
clustered
in
the
N-
terminal
and
Cys-rich
regions
of
the
extracellular
domain
(
ECD
)
and
seven
-transmembrane
domain
.
Disease-causing
mutations
are
uncommon
in
the
C
terminus
of
ECD
.
T
he
aim
of
the
study
was
to
characterize
the
CaSR
mutations
causing
neonatal
severe
hyperparathyroidism
in
a
consanguineous
family
.
Parathyroid
glands
from
the
index
patient
were
stained
for
CaSR
protein
.
The
CaSR
gene
was
sequenced
,
mutations
were
recreated
in
CaSR
cDNA
,
and
HEK
293
cells
were
transfected
with
the
CaSR
mutant
expression
vector
.
Cellular
CaSR
targeting
was
detected
by
immunoblotting
and
immunocytochemistry
;
CaSR
activity
was
assayed
by
inositol
phosphate
accumulation
,
MAPK
activation
,
and
single
-cell
microfluorimetry
.
Immunocytochemistry
showed
reduced
intracellular
CaSR
in
patient
parathyroids
.
An
in
-frame
homozygous
deletion
/
insertion
mutation
,
c
.
1031
>
1034
(
delACAAinsT
)
,
replaced
His
344
-
Asn
345
with
a
single
Leu
in
CaSR
loop
III
.
The
mutant
reduced
cell
surface
expression
of
CaSR
in
transfected
HEK
293
cells
.
Inositol
phosphate
accumulation
,
MAPK
activation
,
and
single
-cell
microfluorimetry
revealed
blunted
signaling
responses
of
the
mutant
receptor
to
changes
in
extracellular
Ca
(
2
+
)
concentration
.
Deletion
of
His
344
-
Asn
345
in
the
ECD
loop
III
region
affects
cell
surface
targeting
of
CaSR
in
transfected
cells
and
in
affected
parathyroid
glands
.
Absence
of
conserved
Asn
345
may
interfere
with
CaSR
folding
or
glycosylation
,
leading
to
poor
protein
targeting
to
the
cell
membrane
.
This
loss
-of-function
mutant
indicates
that
the
ECD
loop
III
is
required
for
CaSR
activity
.
Diseases
Validation
Diseases presenting
"c"
symptom
adrenomyeloneuropathy
alexander disease
cadasil
coats disease
cohen syndrome
dedifferentiated liposarcoma
epidermolysis bullosa simplex
erythropoietic protoporphyria
familial hypocalciuric hypercalcemia
gm1 gangliosidosis
homocystinuria without methylmalonic aciduria
junctional epidermolysis bullosa
kallmann syndrome
oligodontia
papillon-lefèvre syndrome
phenylketonuria
pyruvate dehydrogenase deficiency
von hippel-lindau disease
x-linked adrenoleukodystrophy
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom